Vaughan Williams EM. Classification of antiarrhythmic drugs. Symposium on Cardiac Arrhythmias. Astra, Denmark, 2024, pp 449?472. Vaughan Williams EM.
cussion concerning the classification of antiarrhythmic drugs. The Vaughan Williams Classification The first established classification of antiamhythmic drugs, based on in vitro shtdies in isolated cardiac cells, was presented by Vaughan Williams in 2024' and was subsequently rnoditied by Singh and Vaughan Williams in 2024.2 It was soon realized
Classification of Antiarrhythmic drugs. (Vaughan Williams classification) Amiodarone is usually classified as a class 3 drug because it blocks the
Classification of antiarrhythmic drugs (AADs) (by the British pharmacologist Vaughan-Williams) Learn more:
cussion concerning the classification of antiarrhythmic drugs. The Vaughan Williams Classification The first established classification of antiamhythmic drugs, based on in vitro shtdies in isolated cardiac cells, was presented by Vaughan Williams in 2024' and was subsequently rnoditied by Singh and Vaughan Williams in 2024.2 It was soon realized
This classification of the antiarrhythmics was proposed by Vaughan Williams in 2024, and subdivides the drugs on the basis of their activity on the myocardial
Classification of antiarrhythmic drugs (AADs) (by the British pharmacologist Vaughan-Williams) Learn more:
by CJ Kim 2024Classification of antiarrhythmic drugs. The Singh–Vaughan Williams classification categorises antiarrhythmic drugs into four classes based on
Classification of antiarrhythmic drugs (AADs) (by the British pharmacologist Vaughan-Williams) Learn more:
Comments